Initial Management Steps for Suspected Acute Kidney Injury (AKI)
The initial management of suspected AKI should focus on discontinuing nephrotoxic agents, ensuring adequate volume status, monitoring kidney function, and identifying and treating the underlying cause. 1
Diagnosis and Assessment
AKI is diagnosed when:
- Serum creatinine increases by ≥0.3 mg/dL within 48 hours OR
- Serum creatinine increases by ≥50% from baseline OR
- Urine output is reduced below 0.5 mL/kg/h for >6 hours 1
Immediate investigations to determine AKI etiology:
- Thorough history focusing on:
- Recent nephrotoxic drug exposure (NSAIDs, contrast agents)
- Volume losses (vomiting, diarrhea, hemorrhage)
- Symptoms of infection
- Physical examination to assess:
- Volume status (vital signs, skin turgor, mucous membranes)
- Signs of infection
- Evidence of urinary obstruction
- Thorough history focusing on:
Laboratory and imaging studies:
- Urinalysis and urine microscopy
- Urine chemistry (sodium, urea)
- Blood chemistry (creatinine, BUN, electrolytes)
- Renal ultrasound to rule out obstruction 1
Immediate Management Steps
Discontinue all nephrotoxic agents when possible 1
- NSAIDs, aminoglycosides, contrast agents
- Adjust medication dosing based on kidney function
Ensure adequate volume status and perfusion 1
Hold medications that may worsen AKI
- Diuretics
- ACE inhibitors/ARBs
- Non-selective beta-blockers (especially in cirrhosis) 1
Rigorously search for and treat infections 1
- Blood cultures
- Urine cultures
- Chest radiograph
- In cirrhosis, diagnostic paracentesis to evaluate for spontaneous bacterial peritonitis
- Start broad-spectrum antibiotics if infection is suspected
Monitor kidney function
- Serial serum creatinine measurements
- Urine output monitoring
- Fluid balance assessment 1
Cause-Specific Management
Hypovolemic AKI:
- Volume replacement with crystalloids or albumin
- Monitor response with serum creatinine and urine output 1
Hepatorenal syndrome with AKI (HRS-AKI):
- If serum creatinine remains elevated despite initial management:
- Albumin plus vasoactive agents (terlipressin, norepinephrine, or midodrine/octreotide) 1
- If serum creatinine remains elevated despite initial management:
Obstructive AKI:
- Prompt urologic consultation for decompression
Prevention Strategies
- Avoid nephrotoxic medications when possible 1, 2
- Avoid excessive or unmonitored diuretics 1
- Provide adequate hydration before contrast procedures 3
- Consider N-acetylcysteine for high-risk patients undergoing contrast procedures 3
Common Pitfalls to Avoid
- Delaying discontinuation of nephrotoxic agents
- Excessive fluid administration leading to pulmonary edema, especially in patients with heart failure or cirrhosis 4
- Insufficient fluid resuscitation in hypovolemic patients
- Failure to identify and treat underlying infections
- Using "renal-dose" dopamine, which has been shown to be ineffective and potentially harmful 3
- Relying solely on serum creatinine, which may lag behind actual kidney injury
By following this systematic approach to AKI management, clinicians can potentially prevent further kidney damage and improve patient outcomes.